AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 81 filers reported holding AUDENTES THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $19,562,000 | +2268.3% | 326,905 | +1011.5% | 0.18% | +2442.9% |
| Q3 2019 | $826,000 | -80.2% | 29,411 | -73.2% | 0.01% | -75.9% |
| Q2 2019 | $4,162,000 | +1360.4% | 109,920 | +1405.3% | 0.03% | +866.7% |
| Q1 2019 | $285,000 | +99.3% | 7,302 | +43.3% | 0.00% | +200.0% |
| Q3 2017 | $143,000 | +3.6% | 5,094 | -32.7% | 0.00% | 0.0% |
| Q4 2016 | $138,000 | – | 7,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |